Related Experiment Video
Updated: Jul 15, 2026

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
Published on: June 5, 2015
Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis
Certain genetic markers, specifically the Gm 1,17;21 phenotype, are strongly associated with multiple sclerosis risk in Caucasian populations. Individuals with this Gm phenotype are nearly four times more likely to develop the disease.
Area of Science:
- Immunogenetics
- Neurology
- Human Genetics
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Genetic factors play a significant role in MS susceptibility.
- Immunoglobulin (Gm) allotypes are inherited variations of antibodies that may influence immune responses.
Purpose of the Study:
- To investigate the association between specific Gm allotypes and the risk of developing multiple sclerosis in a Caucasian cohort.
- To determine if the Gm 1,17;21 phenotype confers an increased susceptibility to MS.
Main Methods:
- Serum samples were collected from 70 Caucasian patients diagnosed with multiple sclerosis.
- These samples were analyzed for the presence of nine different Gm markers.
- Statistical analysis was performed to identify significant associations between Gm phenotypes and MS diagnosis.
Main Results:
- A significant association was identified between the Gm 1,17;21 phenotype and multiple sclerosis.
- The relative risk for developing MS in individuals with the Gm 1,17;21 phenotype was calculated to be 3.6.
- Individuals positive for Gm 1,17;21 were found to be approximately four times more likely to develop MS compared to those lacking this phenotype.
Conclusions:
- The Gm 1,17;21 phenotype is a significant genetic risk factor for multiple sclerosis in Caucasian individuals.
- This finding contributes to understanding the genetic underpinnings of MS pathogenesis.
- Further research may explore the immunological mechanisms linking Gm 1,17;21 to MS susceptibility.
More Related Videos
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
09:35Analysis of Somatic Hypermutation in the JH4 intron of Germinal Center B cells from Mouse Peyer's Patches
Published on: April 20, 2021
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology